Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Clinical trial NCT06186401 · RECRUITING

Trial details

NCT number: NCT06186401
Sponsor: Hideho Okada, MD, PhD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

EGFR Gene Mutation Glioblastoma MGMT-Unmethylated Glioblastoma Recurrent Glioblastoma

Start date: 2024-04-30
Primary completion: 2027-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.